BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17569001)

  • 21. Cytogenetic findings in a rare pediatric mixed glioneuronal tumor and review of the literature.
    Coccé MC; Lubieniecki F; Bartuluchi M; Gallego MS
    Childs Nerv Syst; 2009 Nov; 25(11):1485-90. PubMed ID: 19387654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral patterns of clonal evolution in gliomas.
    Vital AL; Tabernero MD; Crespo I; Rebelo O; Tão H; Gomes F; Lopes MC; Orfao A
    Neurogenetics; 2010 May; 11(2):227-39. PubMed ID: 19760258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
    Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
    J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
    Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
    Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas.
    Dalrymple SJ; Herath JF; Ritland SR; Moertel CA; Jenkins RB
    J Neurosurg; 1995 Aug; 83(2):316-23. PubMed ID: 7616278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.
    Idbaih A; Marie Y; Lucchesi C; Pierron G; Manié E; Raynal V; Mosseri V; Hoang-Xuan K; Kujas M; Brito I; Mokhtari K; Sanson M; Barillot E; Aurias A; Delattre JY; Delattre O
    Int J Cancer; 2008 Apr; 122(8):1778-86. PubMed ID: 18076069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
    Kujas M; Lejeune J; Benouaich-Amiel A; Crinière E; Laigle-Donadey F; Marie Y; Mokhtari K; Polivka M; Bernier M; Chretien F; Couvelard A; Capelle L; Duffau H; Cornu P; Broët P; Thillet J; Carpentier AF; Sanson M; Hoang-Xuan K; Delattre JY
    Ann Neurol; 2005 Aug; 58(2):322-6. PubMed ID: 16049942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
    Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
    Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
    Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
    Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization.
    Korshunov A; Sycheva R; Golanov A
    Clin Cancer Res; 2004 Dec; 10(23):7820-6. PubMed ID: 15585613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and cytogenetic factors of prognosis in glial tumors of the brain].
    Dreval' ON; Belokhvostov AS; Feniksov VM
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (4):7-12; discussion 12-3. PubMed ID: 20143607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.
    Broniscer A; Baker SJ; West AN; Fraser MM; Proko E; Kocak M; Dalton J; Zambetti GP; Ellison DW; Kun LE; Gajjar A; Gilbertson RJ; Fuller CE
    J Clin Oncol; 2007 Feb; 25(6):682-9. PubMed ID: 17308273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
    Baronchelli S; Bentivegna A; Redaelli S; Riva G; Butta V; Paoletta L; Isimbaldi G; Miozzo M; Tabano S; Daga A; Marubbi D; Cattaneo M; Biunno I; Dalprà L
    PLoS One; 2013; 8(2):e57462. PubMed ID: 23468990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.
    Jha P; Suri V; Sharma V; Singh G; Sharma MC; Pathak P; Chosdol K; Jha P; Suri A; Mahapatra AK; Kale SS; Sarkar C
    Exp Mol Pathol; 2011 Aug; 91(1):385-93. PubMed ID: 21569770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interphase cytogenetic analysis of gliomas.
    Arnoldus EP; Raap AK; Peters AC; van der Ploeg M
    Clin Neurol Neurosurg; 1992; 94 Suppl():S34-5. PubMed ID: 1320511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH)].
    Herrera JC; Isaza LF; Ramírez JL; Vásquez G; Muñetón CM
    Biomedica; 2010; 30(3):390-400. PubMed ID: 21713341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.